{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T11:03:46Z","timestamp":1782212626089,"version":"3.54.5"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T00:00:00Z","timestamp":1666742400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T00:00:00Z","timestamp":1666742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Harm reduction services and professionals have had to reorganise and adapt to COVID-19 prevention measures while still ensuring health and social services for people who use drugs (PUD).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>To assess the impact of the COVID-19 pandemic on PUD and on the professionals who provide harm reduction services.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A qualitative, exploratory, multicentre design was used. Two focus groups were held with harm reduction professionals, and 40 individual semi-structured interviews were undertaken with PUD in various harm reduction services in Catalonia. Interviews and focus group discussions were transcribed and analysed using thematic content analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Harm reduction services adapted to the pandemic situation by employing methods such as reducing opening hours and closing drop in areas, along with health protection measures such as access control, which in turn led to stress among both professionals and service users. Despite the changes implemented, PUD continued to have access to sterile drug use equipment and methadone treatment. In addition, those who were not in treatment were able to access it rapidly. Regarding their emotional state, the PUD reported that it was worse during the pandemic than before the lockdown, with women affected to a greater extent than men. The harm reduction professionals reported difficulties in managing service users\u2019 compliance with the security measures at the beginning of the lockdown and having had to focus primarily on providing food and shelter for the PUD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>It is important to keep PUD in mind and maintain a harm reduction perspective when implementing confinement measures in situations such as those experienced during the COVID pandemic. Guaranteeing that PUD have their basic needs such as food, hygiene and shelter covered is key.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12954-022-00699-1","type":"journal-article","created":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T04:03:09Z","timestamp":1666756989000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The impact of the COVID-19 pandemic on harm reduction services in Catalonia: the experience of people who use drugs and harm reduction professionals"],"prefix":"10.1186","volume":"19","author":[{"given":"Mar","family":"Bosch-Ar\u00eds","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laia","family":"Gasulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"de Gispert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Segura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Colom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,26]]},"reference":[{"issue":"1","key":"699_CR1","doi-asserted-by":"publisher","first-page":"157","DOI":"10.23750\/abm.v91i1.9397","volume":"91","author":"D Cucinotta","year":"2020","unstructured":"Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed. 2020;91(1):157\u201360. https:\/\/doi.org\/10.23750\/abm.v91i1.9397.","journal-title":"Acta Biomed"},{"issue":"1","key":"699_CR2","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12954-021-00573-6","volume":"18","author":"R Cs\u00e1k","year":"2021","unstructured":"Cs\u00e1k R, Shirley-Beavan S, McHenry AE, Daniels C, Burke-Shyne N. Harm reduction must be recognised an essential public health intervention during crises. Harm Reduct J. 2021;18(1):128. https:\/\/doi.org\/10.1186\/s12954-021-00573-6.","journal-title":"Harm Reduct J"},{"key":"699_CR3","unstructured":"NIDA. COVID-19: potential implications for individuals with substance use disorders; 2020. Retrieved from https:\/\/www.drugabuse.gov\/about-nida\/noras-blog\/2020\/04\/covid-19-potential-implications-individuals-substance-use-disorders."},{"key":"699_CR4","unstructured":"Pompidou Group of the Council of Europe and Correlation-European Harm Reduction Network. COVID-19 and People who use drugs; 2021. Retrieved from https:\/\/rm.coe.int\/2021-ppg-covid19-pwud-eng\/1680a18fff."},{"key":"699_CR5","unstructured":"OEDT. El Problema de La Drogodependencia En La Uni\u00f3n Europea y En Noruega; 2003. Retrieved from https:\/\/www.emcdda.europa.eu\/attachements.cfm\/att_37258_ES_ar2003eu_es.pdf."},{"key":"699_CR6","doi-asserted-by":"publisher","DOI":"10.28931\/riiad.2020.1.04","author":"SE Rodr\u00edguez-Kuri","year":"2020","unstructured":"Rodr\u00edguez-Kuri SE, Guti\u00e9rrez-L\u00f3pez AD, Rios-Salinas MA, Fern\u00e1ndez-C\u00e1ceres C. Tendencias, patr\u00f3n de consumo y perfil sociodemogr\u00e1fico de usuarios de hero\u00edna en tratamiento. Revista Internacional de Investigaci\u00f3n en Adicciones. 2020. https:\/\/doi.org\/10.28931\/riiad.2020.1.04.","journal-title":"Revista Internacional de Investigaci\u00f3n en Adicciones"},{"issue":"1","key":"699_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12916-019-1256-2","volume":"17","author":"L Nyblade","year":"2019","unstructured":"Nyblade L, Stockton MA, Giger K, Bond V, Ekstrand ML, Mc Lean R, Mitchell EMH, Nelson LRE, Sapag JC, Siraprapasiri T, Turan J, Wouters E. Stigma in health facilities: why it matters and how we can change it. BMC Med. 2019;17(1):25. https:\/\/doi.org\/10.1186\/s12916-019-1256-2.","journal-title":"BMC Med"},{"issue":"1","key":"699_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12916-019-1271-3","volume":"17","author":"AL Stangl","year":"2019","unstructured":"Stangl AL, Earnshaw VA, Logie CH, van Brakel W, Simbayi LC, Barr\u00e9 I, Dovidio JF. The health stigma and discrimination framework: a global, crosscutting framework to inform research, intervention development, and policy on health-related stigmas. BMC Med. 2019;17(1):31. https:\/\/doi.org\/10.1186\/s12916-019-1271-3.","journal-title":"BMC Med"},{"issue":"1","key":"699_CR9","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12954-020-00429-5","volume":"17","author":"S Shirley-Beavan","year":"2020","unstructured":"Shirley-Beavan S, Roig A, Burke-Shyne N, Daniels C, Csak R. Women and barriers to harm reduction services: a literature review and initial findings from a qualitative study in Barcelona, Spain. Harm Reduct J. 2020;17(1):78. https:\/\/doi.org\/10.1186\/s12954-020-00429-5.","journal-title":"Harm Reduct J"},{"key":"699_CR10","unstructured":"EMCDDA. Harm reduction: evidence, impacts and challenges; 2010. Retrieved from https:\/\/www.emcdda.europa.eu\/publications\/monographs\/harm-reduction_en."},{"issue":"7","key":"699_CR11","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1111\/j.1360-0443.2005.01089.x","volume":"100","author":"MT Brugal","year":"2005","unstructured":"Brugal MT, Domingo-Salvany A, Puig R, Barrio G, Garc\u00eda de Olalla P, de la Fuente L. Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain. Addiction. 2005;100(7):981\u20139. https:\/\/doi.org\/10.1111\/j.1360-0443.2005.01089.x.","journal-title":"Addiction"},{"key":"699_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.Cd002209","author":"RP Mattick","year":"2003","unstructured":"Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. 2003. https:\/\/doi.org\/10.1002\/14651858.Cd002209.","journal-title":"Cochrane Database Syst Rev"},{"key":"699_CR13","volume-title":"Effectiveness of sterile needle and syringe programming in reducing HIV\/AIDS among injecting drug users","author":"WHO","year":"2004","unstructured":"WHO. Effectiveness of sterile needle and syringe programming in reducing HIV\/AIDS among injecting drug users. Geneva: World Health Organization; 2004."},{"key":"699_CR14","unstructured":"Canal Salut. Reducci\u00f3n de da\u00f1os; 2021. Retrieved from https:\/\/drogues.gencat.cat\/es\/professionals\/reduccio_de_danys\/index.html."},{"key":"699_CR15","unstructured":"Subdirecci\u00f3 General de Drogodepend\u00e8ncies. Sistema d\u2019informaci\u00f3 sobre Drogodepend\u00e8ncies de Catalunya; 2021."},{"key":"699_CR16","unstructured":"European Social Survey. Round 5 Module on Trust in the Police & Courts\u2013 Final Question Design Template; 2011. Retrieved from Centre for Comparative Social Surveys: City University London: https:\/\/www.europeansocialsurvey.org\/docs\/round5\/questionnaire\/ESS5_final_work_family_wellbeing_module_template.pdf."},{"issue":"3","key":"699_CR17","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000376585","volume":"84","author":"CW Topp","year":"2015","unstructured":"Topp CW, \u00d8stergaard SD, S\u00f8ndergaard S, Bech P. The WHO-5 Well-Being Index: a systematic review of the literature. Psychother Psychosom. 2015;84(3):167\u201376. https:\/\/doi.org\/10.1159\/000376585.","journal-title":"Psychother Psychosom"},{"issue":"4","key":"699_CR18","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1159\/000521425","volume":"28","author":"L Grau-L\u00f3pez","year":"2022","unstructured":"Grau-L\u00f3pez L, Daigre C, Palma-Alvarez RF, Sorribes-Puertas M, Serrano-P\u00e9rez P, Quesada-Franco M, Colom J. COVID-19 lockdown and consumption patterns among substance use disorder outpatients: a multicentre study. Eur Addict Res. 2022;28(4):243\u201354. https:\/\/doi.org\/10.1159\/000521425.","journal-title":"Eur Addict Res"},{"issue":"1","key":"699_CR19","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12954-020-00432-w","volume":"17","author":"CA Picchio","year":"2020","unstructured":"Picchio CA, Valencia J, Doran J, Swan T, Pastor M, Martr\u00f3 E, Lazarus JV. The impact of the COVID-19 pandemic on harm reduction services in Spain. Harm Reduct J. 2020;17(1):87. https:\/\/doi.org\/10.1186\/s12954-020-00432-w.","journal-title":"Harm Reduct J"},{"key":"699_CR20","unstructured":"Subdirecci\u00f3 General de Drogodepend\u00e8ncies. Informe d\u2019activitat assistencial. Serveis de reducci\u00f3 de danys; 2020. Ag\u00e8ncia de Salut P\u00fablica de Catalunya. Retrieved from https:\/\/drogues.gencat.cat\/web\/.content\/minisite\/drogues\/professionals\/observatori\/activitat_assist\/SERVEIS-DE-REDUCCIO-DE-DANYS-2020_ok.pdf."},{"key":"699_CR21","unstructured":"Subdirecci\u00f3 General de Drogodepend\u00e8ncies. Informe d\u2019activitat assistencial. Programa d\u2019Intercanvi de Xeringues; 2020. Ag\u00e8ncia de Salut P\u00fablica de Catalunya. Retrieved from https:\/\/drogues.gencat.cat\/web\/.content\/minisite\/drogues\/professionals\/observatori\/activitat_assist\/PROGRAMA-INTERCANVI-XERINGUES-2020_ok.pdf."},{"key":"699_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18094960","author":"J Gaume","year":"2021","unstructured":"Gaume J, Schmutz E, Daeppen JB, Zobel F. Evolution of the illegal substances market and substance users\u2019 social situation and health during the COVID-19 pandemic. Int J Environ Res Public Health. 2021. https:\/\/doi.org\/10.3390\/ijerph18094960.","journal-title":"Int J Environ Res Public Health"},{"key":"699_CR23","unstructured":"Effective Interventions Unit. Rural and remote areas: effective approaches to delivering integrated care for drug users. Scottish Executive; 2005."},{"issue":"4","key":"699_CR24","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1159\/000513883","volume":"27","author":"C Costa Storti","year":"2021","unstructured":"Costa Storti C, Bretteville-Jensen AL, De Grauwe P, Moeller K, Mounteney J, Stevens A. The double effect of COVID-19 confinement measures and economic recession on high-risk drug users and drug services. Eur Addict Res. 2021;27(4):239\u201341. https:\/\/doi.org\/10.1159\/000513883.","journal-title":"Eur Addict Res"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-022-00699-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-022-00699-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-022-00699-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T04:04:24Z","timestamp":1666757064000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-022-00699-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,26]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["699"],"URL":"https:\/\/doi.org\/10.1186\/s12954-022-00699-1","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,26]]},"assertion":[{"value":"10 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"118"}}